You are viewing content for the region United States

Certain BTG products may not be available within the chosen location and indications may differ from your country's approved use.

Change to Canada »
Remain viewing United States »

This website is intended for US Healthcare Professionals only

How DigiFab® Is Produced

DigiFab® Digoxin Immune Fab (Ovine) is produced through a time intensive, complex process. Immunogens consisting of an analog of digoxin medication are produced in a laboratory and used to immunize sheep. These immunogens are recognized by the immune system as foreign antigens to which antibodies are produced. These antibodies are then collected, separated, purified, and formulated into the drug DigiFab® Digoxin Immune Fab (Ovine).1

Read about mechanism of action of DigiFab® »

References

  1. Data on file. BTG International Inc.

To report an adverse event or for 24-hour medical information, call 1-877-377-3784